These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38035457)

  • 1. Spatial distributions of white matter hyperintensities on brain MRI: A pooled analysis of individual participant data from 11 memory clinic cohorts.
    Coenen M; Biessels GJ; DeCarli C; Fletcher EF; Maillard PM; ; Barkhof F; Barnes J; Benke T; Boomsma JMF; P L H Chen C; Dal-Bianco P; Dewenter A; Duering M; Enzinger C; Ewers M; Exalto LG; Franzmeier N; Groeneveld O; Hilal S; Hofer E; Koek HL; Maier AB; McCreary CR; Papma JM; Paterson RW; Pijnenburg YAL; Rubinski A; Schmidt R; Schott JM; Slattery CF; Smith EE; Sudre CH; Steketee RME; van den Berg E; van der Flier WM; Venketasubramanian N; Vernooij MW; Wolters FJ; Xin X; Biesbroek JM; Kuijf HJ
    Neuroimage Clin; 2023; 40():103547. PubMed ID: 38035457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic white matter hyperintensity locations for cognitive impairment: A multicenter lesion-symptom mapping study in 3525 memory clinic patients.
    Coenen M; Kuijf HJ; Huenges Wajer IMC; Duering M; Wolters FJ; Fletcher EF; Maillard PM; ; Barkhof F; Barnes J; Benke T; Boomsma JMF; Chen CPLH; Dal-Bianco P; Dewenter A; Enzinger C; Ewers M; Exalto LG; Franzmeier N; Groeneveld O; Hilal S; Hofer E; Koek DL; Maier AB; McCreary CR; Padilla CS; Papma JM; Paterson RW; Pijnenburg YAL; Rubinski A; Schmidt R; Schott JM; Slattery CF; Smith EE; Steketee RME; Sudre CH; van den Berg E; van der Flier WM; Venketasubramanian N; Vernooij MW; Xin X; DeCarli C; Biessels GJ; Biesbroek JM
    Alzheimers Dement; 2023 Jun; 19(6):2420-2432. PubMed ID: 36504357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the distribution of white matter hyperintensities due to ageing on MRI images using Bayesian inference.
    Sundaresan V; Griffanti L; Kindalova P; Alfaro-Almagro F; Zamboni G; Rothwell PM; Nichols TE; Jenkinson M
    Neuroimage; 2019 Jan; 185():434-445. PubMed ID: 30359730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a deep learning approach for the segmentation of brain tissues and white matter hyperintensities of presumed vascular origin in MRI.
    Moeskops P; de Bresser J; Kuijf HJ; Mendrik AM; Biessels GJ; Pluim JPW; Išgum I
    Neuroimage Clin; 2018; 17():251-262. PubMed ID: 29159042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.
    Tran P; Thoprakarn U; Gourieux E; Dos Santos CL; Cavedo E; Guizard N; Cotton F; Krolak-Salmon P; Delmaire C; Heidelberg D; Pyatigorskaya N; Ströer S; Dormont D; Martini JB; Chupin M;
    Neuroimage Clin; 2022; 33():102940. PubMed ID: 35051744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of white matter hyperintensities: Lesion patterns, cognition, and microstructural changes.
    Zeng W; Chen Y; Zhu Z; Gao S; Xia J; Chen X; Jia J; Zhang Z
    J Cereb Blood Flow Metab; 2020 Dec; 40(12):2454-2463. PubMed ID: 31865841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
    Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
    Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
    Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
    Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Score of Perivascular Space Dilatation and White Matter Hyperintensities in Patients with Normal Cognition, Mild Cognitive Impairment, and Dementia.
    Zdanovskis N; Platkājis A; Kostiks A; Šneidere K; Stepens A; Naglis R; Karelis G
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888606
    [No Abstract]   [Full Text] [Related]  

  • 12. Spatial distribution and cognitive impact of cerebrovascular risk-related white matter hyperintensities.
    Veldsman M; Kindalova P; Husain M; Kosmidis I; Nichols TE
    Neuroimage Clin; 2020; 28():102405. PubMed ID: 32971464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of different white matter hyperintensities patterns on cognition: A cross-sectional and longitudinal study.
    Wang J; Zhou Y; He Y; Li Q; Zhang W; Luo Z; Xue R; Lou M
    Neuroimage Clin; 2022; 34():102978. PubMed ID: 35255417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE4 and Confluent White Matter Hyperintensities Have a Synergistic Effect on Episodic Memory Impairment in Prodromal Dementia.
    Kumar D; Yatawara C; Wang B; Wong B; Tan YJ; Zailan FZ; Ng KP; Kandiah N
    J Alzheimers Dis; 2022; 87(3):1103-1114. PubMed ID: 35431245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional Architecture Underlies White Matter Hyperintensities with and without Cognitive Impairment.
    Zhu W; Huang H; Yang S; Luo X; Zhu W; Xu S; Meng Q; Zuo C; Zhao K; Liu H; Liu Y; Wang W
    J Alzheimers Dis; 2019; 71(2):461-476. PubMed ID: 31403946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered static and dynamic functional network connectivity related to cognitive decline in individuals with white matter hyperintensities.
    Chen H; Xu J; Lv W; Hu Z; Ke Z; Qin R; Xu Y
    Behav Brain Res; 2023 Aug; 451():114506. PubMed ID: 37230298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anatomical knowledge-based MRI deep learning pipeline for white matter hyperintensity quantification associated with cognitive impairment.
    Liang L; Zhou P; Lu W; Guo X; Ye C; Lv H; Wang T; Ma T
    Comput Med Imaging Graph; 2021 Apr; 89():101873. PubMed ID: 33610084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
    Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.